Search Results for FY2017

Showing 1 – 3

Government Spending Bill Would Boost FDA Funds by Almost $40M By Zachary Brennan - Published 01 May 2017

The US House and Senate appropriations committees on Monday released government spending bills through the end of this fiscal year, offering the US Food and Drug Administration (FDA) a boost in discretionary spending.

Categories: News, US, FDA, Biologics and biotechnology, Drugs, Government affairs, Medical Devices

Tags: FDA budget, FY2017 budget, FDA user fees

FDA Unveils User Fee Rates for FY 2017 By Michael Mezher - Published 01 August 2016

In the late 1980s, the US lagged behind Europe in drug approvals, and individual drug reviews often took years to complete. These lengthy approval times were a significant source of frustration not only for patients and drug companies, but for the US Food and Drug Administration (FDA) itself.

Categories: News, US, FDA, Biologics and biotechnology, Generic drugs, Prescription drugs, Medical Devices

Tags: User Fees, PDUFA, BsUFA, MDUFA, GDUFA, FY2017

Senators Urge Obama to Take Action on Drug Prices By Zachary Brennan - Published 03 February 2016

Policy solutions to bring down the rising tide of prescription drug prices should be included in next year’s budget, eight senators said in a letter sent to President Barack Obama on Tuesday.

Categories: News, US, Crisis management, Drugs, Government affairs, Postmarket surveillance, Reimbursement

Tags: drug prices, Medicare Part D, government drug price negotiations, Obama budget FY2017